Médecine Intensive Réanimation, Centre Hospitalier Régional et Universitaire de Tours, 37044, Tours, France.
Faculté de Médecine, Université François Rabelais, Tours, France.
Intensive Care Med. 2017 Jun;43(6):785-794. doi: 10.1007/s00134-017-4700-9. Epub 2017 Feb 14.
Critically ill patients, among whom acute kidney injury is common, are often considered particularly vulnerable to iodinated contrast medium nephrotoxicity. However, the attributable incidence remains uncertain given the paucity of observational studies including a control group. This study assessed acute kidney injury incidence attributable to iodinated contrast media in critically ill patients based on new data accounting for sample and effect size and including a control group.
Systematic review of studies measuring incidence of acute kidney injury in critically ill patients following contrast medium exposure compared to matched unexposed patients. Patient-level meta-analysis implementing a Bayesian nested mixed effects multiple logistic regression model.
Ten studies were identified; only four took into account the baseline acute kidney injury risk, three by patient matching (560 patients). Objective meta-analysis of these three studies (vague and impartial a priori hypothesis concerning attributable acute kidney injury risk) did not find that iodinated contrast media increased the incidence of acute kidney injury (odds ratio 0.95, 95% highest posterior density interval 0.45-1.62). Bayesian analysis demonstrated that, to conclude in favor of a statistically significant incidence of acute kidney injury attributable to contrast media despite this observed lack of association, one's a priori belief would have to be very strongly biased, assigning to previous uncontrolled reports 3-12 times the weight of evidence strength provided by the matched studies including a control group.
Meta-analysis of matched cohort studies of iodinated contrast medium exposure does not support a significant incidence of acute kidney injury attributable to iodinated contrast media in critically ill patients.
危重症患者常并发急性肾损伤,被认为尤其容易发生碘造影剂肾毒性。然而,鉴于缺乏包括对照组的观察性研究,其归因发病率仍不确定。本研究根据新数据(考虑到样本量和效应大小,并包括对照组)评估了碘造影剂在危重症患者中导致急性肾损伤的发病率。
系统性回顾比较造影剂暴露后与匹配未暴露患者的危重症患者急性肾损伤发病率的研究。采用贝叶斯嵌套混合效应多逻辑回归模型进行患者水平荟萃分析。
确定了 10 项研究;只有 4 项研究考虑了基线急性肾损伤风险,其中 3 项通过患者匹配(560 例患者)。对这 3 项研究(关于归因急性肾损伤风险的模糊和不偏不倚的先验假设)进行客观荟萃分析,未发现碘造影剂增加急性肾损伤的发生率(比值比 0.95,95%最高后验密度区间 0.45-1.62)。贝叶斯分析表明,尽管观察到没有关联,但为了得出碘造影剂导致的急性肾损伤发病率具有统计学意义的结论,需要非常强烈地偏向于先验信念,将以前未对照的报告赋予 3-12 倍于包括对照组的匹配研究提供的证据强度的权重。
碘造影剂暴露的匹配队列研究荟萃分析不支持碘造影剂在危重症患者中导致急性肾损伤的发病率显著增加。